Oncology & Cancer
Possible association for bortezomib therapy, chalazia
(HealthDay)—There is a possible correlation between bortezomib use and chalazia, according to a report published online Oct. 15 in JAMA Ophthalmology.
Oct 19, 2015
0
6
News tagged with bortezomib
Oncology & Cancer
Results of major myeloma treatment trial published
The addition of bortezomib to a standard two-drug regimen for multiple myeloma patients significantly lengthened the time before their cancer returned, and significantly lengthened their lives, according to clinical trial ...
Dec 22, 2016
0
1
Medications
Cancer drug may also work for scleroderma
A drug used to treat cancer may also be effective in diseases that cause scarring of the internal organs or skin, such as pulmonary fibrosis or scleroderma.
Sep 22, 2011
0
0
Oncology & Cancer
Multiple sclerosis drug could reduce painful side effects of common cancer treatment
Researchers from the Saint Louis University School of Medicine have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib. The study, which will be published ...
Apr 27, 2018
0
133
Medications
'Game-changing' myeloma drug combo approved for NHS use in England
A new treatment for people with multiple myeloma will now be available on the NHS in England.
Mar 12, 2019
0
2
Medications
Cancer drug approved for NHS use in England gives some multiple myeloma patients another option
A drug has been made available on the NHS in England for adults with a type of blood cancer called multiple myeloma who cannot receive standard treatment.
May 20, 2019
0
1
Oncology & Cancer
In the lab and clinic, researchers develop a new therapy for blood cancers
Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving ...
Jun 2, 2011
0
0
Oncology & Cancer
Powerful myeloma treatment regimen shows promise for AL amyloidosis
Two studies published today in Blood, the Journal of the American Society of Hematology (ASH), demonstrate preliminary success of an effective multiple myeloma (MM) regimen in patients with AL amyloidosis, a rare and devastating ...
Feb 13, 2012
0
0
Oncology & Cancer
Scientists find new molecule to target in pancreatic cancer treatment
Researchers at Mayo Clinic in Florida have identified a new target to improve treatment of pancreatic ductal adenocarcinoma cancer, which accounts for more than 95 percent of pancreatic cancer cases. This fast-growing, often ...
Jan 3, 2013
0
0
Oncology & Cancer
Possible new therapy for the treatment of myeloma
(Medical Xpress)—Research from Karolinska Institutet shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common ...
Sep 5, 2012
0
0
Bortezomib
Bortezomib (INN, originally codenamed PS-341; marketed as Velcade by Millennium Pharmaceuticals) is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma. In multiple myeloma, complete clinical responses have been obtained in patients with otherwise refractory or rapidly advancing disease.
This text uses material from Wikipedia, licensed under CC BY-SA
